As exhibited in Table 1, tumor grade, histopathological classification, IDH status, and molecular classification were remarkably correlated with TP73 expression; while the clinical phenotypes of patients’ age, gender, MGMT promoter methylation status, TERT promoter and ATRX mutation status showed no significant association with TP73 expression (Table 1). This evidence concerns the gene TP73 and neoplasm.